-5%
Catium Trio is a triple-combination inhalation therapy containing:
✔ Indacaterol Acetate – an ultra-LABA (long-acting beta-2 agonist) that works as a bronchodilator to relax airway muscles and improve breathing.
✔ Glycopyrronium Bromide – an ultra-LAMA (long-acting muscarinic antagonist) that helps prevent bronchoconstriction by blocking acetylcholine receptors.
✔ Mometasone Furoate – a high-affinity corticosteroid with potent anti-inflammatory properties to reduce airway inflammation and hypersensitivity.
This combination helps enhance lung function, reduce asthma symptoms, and prevent exacerbations, improving overall respiratory health for patients with chronic asthma.
Catium Trio is a specialized inhalation powder medication designed for the maintenance treatment of asthma and to help prevent asthma exacerbations in adult patients. It is specifically recommended for individuals who are not adequately controlled with a combination therapy of a long-acting beta-2 agonist (LABA) and an inhaled corticosteroid (ICS).